Clinical Trial Update: Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing cyclosporine microemulsion and tacrolimus in kidney transplant recipients to evaluate the rate of new-onset diabetes mellitus; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Tacrolimus (Tacrolimus)
• cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis | Conditions: Kidney Transplant | Phase 4 | Status: COMPLETED